Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
UW Hindbrain Malformation Research Program, |
RCV000201670 | SCV000256447 | pathogenic | Familial aplasia of the vermis | 2015-02-23 | criteria provided, single submitter | research | |
Centre for Mendelian Genomics, |
RCV000414929 | SCV000492770 | pathogenic | Polydactyly; Global developmental delay; Rotary nystagmus; Limb undergrowth; Chronic kidney disease | 2015-10-23 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000665372 | SCV000789485 | likely pathogenic | Bardet-Biedl syndrome 13; Meckel syndrome, type 1; Joubert syndrome 28 | 2017-02-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000691391 | SCV000819167 | pathogenic | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2023-12-21 | criteria provided, single submitter | clinical testing | This variant, c.1115_1117del, results in the deletion of 1 amino acid(s) of the MKS1 protein (p.Ser372del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs754279998, gnomAD 0.003%). This variant has been observed in individual(s) with Joubert syndrome (PMID: 24886560, 26092869, 27570071). This variant is also known as c.1085_1088delCCT (p.S362del). ClinVar contains an entry for this variant (Variation ID: 217677). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. For these reasons, this variant has been classified as Pathogenic. |
Centre for Mendelian Genomics, |
RCV001197092 | SCV001367728 | pathogenic | Bardet-Biedl syndrome 13 | 2016-01-01 | criteria provided, single submitter | clinical testing | This variant was classified as: Pathogenic. This variant was detected in homozygous state. |
Baylor Genetics | RCV001197092 | SCV004194928 | pathogenic | Bardet-Biedl syndrome 13 | 2023-12-27 | criteria provided, single submitter | clinical testing | |
Laboratory of Medical Genetics, |
RCV001272923 | SCV005051861 | likely pathogenic | Meckel syndrome, type 1 | 2024-02-01 | criteria provided, single submitter | curation | |
OMIM | RCV000241545 | SCV000301466 | pathogenic | Joubert syndrome 28 | 2016-09-23 | no assertion criteria provided | literature only | |
Natera, |
RCV001272923 | SCV001455370 | pathogenic | Meckel syndrome, type 1 | 2020-09-16 | no assertion criteria provided | clinical testing | |
Gene Discovery Core- |
RCV000241545 | SCV001768735 | pathogenic | Joubert syndrome 28 | 2020-02-14 | no assertion criteria provided | research | This variant is interpreted as Pathogenic for Joubert syndrome; Autosomal Recessive. PM1- Located in a mutational hot spot and/or critical and well-established functional domain (e.g., active site of an enzyme) without benign variation. PM2- Absent from controls or at extremely low frequency if recessive (0 homozygotes in gnomad). PM4- Protein length changes as a result of in-frame deletions/insertions in a non-repeat region or stop-loss variants. PP3- Multiple lines of computational evidence support a deleterious effect on the gene or gene product (conservation, evolutionary, splicing impact, etc.). PP5: Reputable source recently reports variant as pathogenic, but the evidence is not available to the laboratory to perform an independent evaluation, 6 nonconflicting ClinVar entries, (PMIDs: 24886560, 26092869, 26490104 and 27570071). |
Gene |
RCV000241545 | SCV001792275 | not provided | Joubert syndrome 28 | no assertion provided | literature only |